Veradermics
Manufacturing · Connecticut, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
470 James St Ste 14, New Haven, Connecti...Phone Number
(228) 372-3376Website
www.veradermics.comRevenue
-Stock Symbol
MANEIndustry
About Veradermics
Veradermics Org Chart
Is Veradermics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Veradermics has new funding data
Website visits: Recent activity has been detected on your website
Check if Veradermics has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Veradermics recently announced quarterly report
Check out if Veradermics is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Veradermics
Product Launch: Get notified when Veradermics launches new products
Veradermics, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Veradermics had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Veradermics
Compare insights from companies similar to Veradermics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Veradermics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Veradermics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Veradermics.
Veradermics financials insights
Gather financial insights about Veradermics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Series B
$75M
Series C
$150M
Stock/Share Issuance
$135M
IPO
$256.3M
Veradermics Tech Stack
A closer look at the technologies used by Veradermics
Most Recent Scoops
Veradermics News & Media
Hair Loss Biotechs Emerge As Wall Street's Newest Growth Trade
Hair loss biotechs Veradermics, Absci, and Cosmo are drawing investor bets on a market untouched since the 1990s.Veradermics CTO sells 43.5K shares after option | MANE Insider Trading - Stock Titan
CTO Timothy Durso exercised 3,452 options at $12.19, then sold 43,500 Veradermics shares at $106.71–$111.28 in Rule 10b5-1 trades on Aug. 17, 2026.Veradermics, Incorporated (MANE) Discusses Positive Female Results From Phase II Study of VDPHL01 for Pattern Hair Loss Transcript
Veradermics, Incorporated (MANE) Discusses Positive Female Results From Phase II Study of VDPHL01 for Pattern Hair Loss July 15, 2026 8:00 AM EDTCompany...Hair loss biotech Veradermics, up 656% since its IPO, credits the obesity boom - BioSpace
After debuting on the public markets with $256.3 million and raking in an additional $472 million, Veradermics has emerged as one of biotech’s biggest post-IPO standouts. CEO Reid Waldman credits the weight loss craze for establishing consumer-driven channels.
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Veradermics
Veradermics is a clinical-stage biopharmaceutical company developing innovative, non-hormonal treatments for dermatologic and aesthetic conditions, with a lead program focused on oral therapies for hair regrowth.... Read More


